Pathway Name	Avg Num Perturbations	Total Perturbations	Num Entities	Min Mean Truth	Max Mean Truth	Min Mean Within	Max Mean Within	Min Mean Any	Max Mean Within
HIF-1-alpha transcription factor network	5.0	407.0	76.0	-0.592	0.051	1000.0	-1000.0	-0.039	-1000.0
IL4-mediated signaling events	3.0	276.0	91.0	-0.77	0.584	1000.0	-1000.0	-0.098	-1000.0
Endothelins	3.0	322.0	96.0	-0.387	0.039	1000.0	-1000.0	-0.041	-1000.0
Signaling mediated by p38-alpha and p38-beta	3.0	142.0	44.0	-0.161	0.039	1000.0	-1000.0	-0.024	-1000.0
IL23-mediated signaling events	3.0	204.0	60.0	-0.449	0.037	1000.0	-1000.0	-0.055	-1000.0
Osteopontin-mediated events	2.0	82.0	38.0	-0.12	0.043	1000.0	-1000.0	-0.044	-1000.0
Signaling events mediated by the Hedgehog family	2.0	139.0	52.0	-0.183	0.052	1000.0	-1000.0	-0.034	-1000.0
Fc-epsilon receptor I signaling in mast cells	2.0	227.0	97.0	-0.138	0.039	1000.0	-1000.0	-0.05	-1000.0
Ephrin B reverse signaling	2.0	119.0	48.0	-0.211	0.039	1000.0	-1000.0	-0.024	-1000.0
TCGA08_p53	2.0	19.0	7.0	-0.052	0.039	1000.0	-1000.0	-0.005	-1000.0
IL27-mediated signaling events	2.0	149.0	51.0	-0.222	0.18	1000.0	-1000.0	-0.049	-1000.0
Wnt signaling	2.0	15.0	7.0	-0.067	0.037	1000.0	-1000.0	-0.017	-1000.0
Calcineurin-regulated NFAT-dependent transcription in lymphocytes	2.0	195.0	68.0	-0.387	0.147	1000.0	-1000.0	-0.057	-1000.0
TCGA08_retinoblastoma	2.0	18.0	8.0	-0.039	0.05	1000.0	-1000.0	-0.005	-1000.0
EGFR-dependent Endothelin signaling events	2.0	53.0	21.0	-0.094	0.055	1000.0	-1000.0	-0.026	-1000.0
Syndecan-4-mediated signaling events	2.0	141.0	67.0	-0.113	0.047	1000.0	-1000.0	-0.034	-1000.0
Plasma membrane estrogen receptor signaling	2.0	174.0	86.0	-0.24	0.228	1000.0	-1000.0	-0.052	-1000.0
FOXM1 transcription factor network	2.0	116.0	51.0	-0.447	0.037	1000.0	-1000.0	-0.098	-1000.0
Caspase cascade in apoptosis	1.0	92.0	74.0	-0.049	0.05	1000.0	-1000.0	-0.033	-1000.0
IL12-mediated signaling events	1.0	156.0	87.0	-0.244	0.039	1000.0	-1000.0	-0.045	-1000.0
Syndecan-1-mediated signaling events	1.0	36.0	34.0	-0.126	0.039	1000.0	-1000.0	-0.048	-1000.0
Visual signal transduction: Cones	1.0	71.0	38.0	-0.126	0.048	1000.0	-1000.0	-0.001	-1000.0
Ephrin A  reverse signaling	1.0	7.0	7.0	0.0	0.029	1000.0	-1000.0	0.0	-1000.0
Noncanonical Wnt signaling pathway	1.0	35.0	26.0	-0.067	0.039	1000.0	-1000.0	-0.064	-1000.0
Thromboxane A2 receptor signaling	1.0	160.0	105.0	-0.113	0.05	1000.0	-1000.0	-0.039	-1000.0
Arf6 signaling events	1.0	71.0	62.0	-0.094	0.056	1000.0	-1000.0	-0.018	-1000.0
Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met)	1.0	90.0	85.0	-0.119	0.042	1000.0	-1000.0	-0.049	-1000.0
Signaling events mediated by PTP1B	1.0	92.0	76.0	-0.142	0.103	1000.0	-1000.0	-0.039	-1000.0
FOXA2 and FOXA3 transcription factor networks	1.0	72.0	46.0	-0.228	0.043	1000.0	-1000.0	-0.074	-1000.0
BMP receptor signaling	1.0	107.0	81.0	-0.184	0.081	1000.0	-1000.0	-0.034	-1000.0
mTOR signaling pathway	1.0	73.0	53.0	-0.08	0.043	1000.0	-1000.0	-0.045	-1000.0
IFN-gamma pathway	1.0	85.0	68.0	-0.055	0.055	1000.0	-1000.0	-0.051	-1000.0
amb2 Integrin signaling	1.0	155.0	82.0	-0.137	0.05	1000.0	-1000.0	-0.031	-1000.0
Nectin adhesion pathway	1.0	95.0	63.0	-0.094	0.058	1000.0	-1000.0	-0.034	-1000.0
Glucocorticoid receptor regulatory network	1.0	205.0	114.0	-0.347	0.08	1000.0	-1000.0	-0.05	-1000.0
Reelin signaling pathway	1.0	56.0	56.0	-0.077	0.066	1000.0	-1000.0	-0.033	-1000.0
TRAIL signaling pathway	1.0	81.0	48.0	-0.043	0.039	1000.0	-1000.0	-0.025	-1000.0
IL1-mediated signaling events	1.0	103.0	62.0	-0.13	0.046	1000.0	-1000.0	-0.032	-1000.0
HIF-2-alpha transcription factor network	1.0	48.0	43.0	-0.153	0.072	1000.0	-1000.0	-0.035	-1000.0
S1P1 pathway	1.0	63.0	36.0	-0.164	0.037	1000.0	-1000.0	-0.035	-1000.0
FAS signaling pathway (CD95)	1.0	47.0	47.0	-0.128	0.047	1000.0	-1000.0	-0.047	-1000.0
Syndecan-3-mediated signaling events	1.0	57.0	35.0	-0.154	0.068	1000.0	-1000.0	-0.027	-1000.0
TCR signaling in naïve CD8+ T cells	1.0	166.0	93.0	-0.041	0.055	1000.0	-1000.0	-0.041	-1000.0
HIV-1 Nef: Negative effector of Fas and TNF-alpha	1.0	49.0	45.0	-0.074	0.042	1000.0	-1000.0	-0.049	-1000.0
Glypican 2 network	1.0	6.0	4.0	-0.014	0.0	1000.0	-1000.0	-0.0	-1000.0
Calcium signaling in the CD4+ TCR pathway	1.0	40.0	31.0	-0.15	0.039	1000.0	-1000.0	-0.038	-1000.0
Nongenotropic Androgen signaling	1.0	54.0	52.0	-0.053	0.044	1000.0	-1000.0	-0.028	-1000.0
Signaling events mediated by VEGFR1 and VEGFR2	1.0	191.0	125.0	-0.076	0.059	1000.0	-1000.0	-0.039	-1000.0
IL6-mediated signaling events	1.0	123.0	75.0	-0.292	0.054	1000.0	-1000.0	-0.035	-1000.0
BCR signaling pathway	1.0	137.0	99.0	-0.154	0.067	1000.0	-1000.0	-0.052	-1000.0
Insulin Pathway	1.0	82.0	74.0	-0.089	0.073	1000.0	-1000.0	-0.042	-1000.0
Angiopoietin receptor Tie2-mediated signaling	1.0	89.0	88.0	-0.083	0.06	1000.0	-1000.0	-0.068	-1000.0
Visual signal transduction: Rods	1.0	93.0	52.0	-0.126	0.05	1000.0	-1000.0	-0.032	-1000.0
E-cadherin signaling in keratinocytes	1.0	44.0	43.0	-0.047	0.038	1000.0	-1000.0	-0.032	-1000.0
Signaling events mediated by Stem cell factor receptor (c-Kit)	1.0	96.0	78.0	-0.086	0.04	1000.0	-1000.0	-0.061	-1000.0
LPA4-mediated signaling events	0.0	5.0	12.0	-0.026	0.055	1000.0	-1000.0	-0.027	-1000.0
ErbB2/ErbB3 signaling events	0.0	20.0	65.0	-0.033	0.078	1000.0	-1000.0	-0.054	-1000.0
Regulation of nuclear SMAD2/3 signaling	0.0	63.0	136.0	-0.214	0.21	1000.0	-1000.0	-0.046	-1000.0
Coregulation of Androgen receptor activity	0.0	46.0	76.0	-0.07	0.045	1000.0	-1000.0	-0.029	-1000.0
Regulation of cytoplasmic and nuclear SMAD2/3 signaling	0.0	4.0	23.0	-0.012	0.065	1000.0	-1000.0	-0.035	-1000.0
Nephrin/Neph1 signaling in the kidney podocyte	0.0	12.0	34.0	-0.046	0.081	1000.0	-1000.0	-0.034	-1000.0
Canonical NF-kappaB pathway	0.0	12.0	39.0	-0.0	0.081	1000.0	-1000.0	-0.016	-1000.0
Signaling events mediated by HDAC Class II	0.0	28.0	75.0	-0.101	0.072	1000.0	-1000.0	-0.02	-1000.0
ErbB4 signaling events	0.0	33.0	69.0	-0.151	0.076	1000.0	-1000.0	-0.042	-1000.0
BARD1 signaling events	0.0	6.0	57.0	-0.071	0.076	1000.0	-1000.0	-0.038	-1000.0
Sphingosine 1-phosphate (S1P) pathway	0.0	14.0	28.0	-0.012	0.052	1000.0	-1000.0	-0.014	-1000.0
PLK2 and PLK4 events	0.0	2.0	3.0	-0.005	0.037	1000.0	-1000.0	-0.006	-1000.0
Circadian rhythm pathway	0.0	12.0	22.0	-0.094	0.039	1000.0	-1000.0	-0.026	-1000.0
Lissencephaly gene (LIS1) in neuronal migration and development	0.0	33.0	54.0	-0.074	0.05	1000.0	-1000.0	-0.033	-1000.0
JNK signaling in the CD4+ TCR pathway	0.0	5.0	17.0	-0.01	0.073	1000.0	-1000.0	-0.02	-1000.0
Syndecan-2-mediated signaling events	0.0	63.0	69.0	-0.154	0.062	1000.0	-1000.0	-0.044	-1000.0
a4b1 and a4b7 Integrin signaling	0.0	0.0	5.0	0.035	0.055	1000.0	-1000.0	0.017	-1000.0
Cellular roles of Anthrax toxin	0.0	18.0	39.0	-0.041	0.045	1000.0	-1000.0	-0.024	-1000.0
Hedgehog signaling events mediated by Gli proteins	0.0	47.0	65.0	-0.289	0.075	1000.0	-1000.0	-0.041	-1000.0
Presenilin action in Notch and Wnt signaling	0.0	43.0	61.0	-0.113	0.068	1000.0	-1000.0	-0.047	-1000.0
Aurora A signaling	0.0	9.0	60.0	-0.006	0.07	1000.0	-1000.0	-0.012	-1000.0
p75(NTR)-mediated signaling	0.0	98.0	125.0	-0.05	0.073	1000.0	-1000.0	-0.041	-1000.0
Arf6 downstream pathway	0.0	30.0	43.0	-0.039	0.055	1000.0	-1000.0	-0.032	-1000.0
Aurora C signaling	0.0	4.0	7.0	-0.039	0.026	1000.0	-1000.0	-0.017	-1000.0
Glypican 1 network	0.0	38.0	48.0	-0.016	0.051	1000.0	-1000.0	-0.02	-1000.0
EPO signaling pathway	0.0	22.0	55.0	-0.017	0.08	1000.0	-1000.0	-0.032	-1000.0
PLK1 signaling events	0.0	30.0	85.0	-0.08	0.058	1000.0	-1000.0	-0.038	-1000.0
Insulin-mediated glucose transport	0.0	7.0	32.0	-0.012	0.048	1000.0	-1000.0	-0.018	-1000.0
PDGFR-alpha signaling pathway	0.0	32.0	44.0	-0.078	0.06	1000.0	-1000.0	-0.029	-1000.0
Class I PI3K signaling events mediated by Akt	0.0	41.0	68.0	-0.03	0.068	1000.0	-1000.0	-0.03	-1000.0
Ceramide signaling pathway	0.0	63.0	76.0	-0.077	0.058	1000.0	-1000.0	-0.028	-1000.0
Paxillin-independent events mediated by a4b1 and a4b7	0.0	12.0	37.0	-0.028	0.082	1000.0	-1000.0	-0.03	-1000.0
Signaling events mediated by HDAC Class III	0.0	10.0	40.0	-0.065	0.066	1000.0	-1000.0	-0.026	-1000.0
Signaling events regulated by Ret tyrosine kinase	0.0	57.0	82.0	-0.052	0.062	1000.0	-1000.0	-0.056	-1000.0
S1P5 pathway	0.0	13.0	17.0	-0.012	0.039	1000.0	-1000.0	-0.008	-1000.0
ceramide signaling pathway	0.0	13.0	49.0	-0.049	0.042	1000.0	-1000.0	-0.035	-1000.0
RXR and RAR heterodimerization with other nuclear receptor	0.0	31.0	52.0	-0.031	0.065	1000.0	-1000.0	-0.025	-1000.0
Role of Calcineurin-dependent NFAT signaling in lymphocytes	0.0	10.0	83.0	-0.024	0.072	1000.0	-1000.0	-0.039	-1000.0
Signaling events mediated by HDAC Class I	0.0	15.0	104.0	-0.047	0.082	1000.0	-1000.0	-0.033	-1000.0
FoxO family signaling	0.0	43.0	64.0	-0.095	0.059	1000.0	-1000.0	-0.038	-1000.0
Signaling mediated by p38-gamma and p38-delta	0.0	12.0	15.0	-0.053	0.035	1000.0	-1000.0	-0.033	-1000.0
Retinoic acid receptors-mediated signaling	0.0	26.0	58.0	-0.038	0.071	1000.0	-1000.0	-0.038	-1000.0
Paxillin-dependent events mediated by a4b1	0.0	8.0	36.0	-0.07	0.072	1000.0	-1000.0	-0.031	-1000.0
Atypical NF-kappaB pathway	0.0	4.0	31.0	-0.0	0.067	1000.0	-1000.0	-0.019	-1000.0
IL2 signaling events mediated by PI3K	0.0	26.0	58.0	-0.012	0.079	1000.0	-1000.0	-0.037	-1000.0
Integrins in angiogenesis	0.0	63.0	84.0	-0.109	0.067	1000.0	-1000.0	-0.042	-1000.0
Canonical Wnt signaling pathway	0.0	46.0	51.0	-0.113	0.072	1000.0	-1000.0	-0.046	-1000.0
EPHB forward signaling	0.0	81.0	85.0	-0.055	0.057	1000.0	-1000.0	-0.056	-1000.0
Regulation of p38-alpha and p38-beta	0.0	26.0	54.0	-0.075	0.078	1000.0	-1000.0	-0.025	-1000.0
Effects of Botulinum toxin	0.0	12.0	26.0	-0.039	0.034	1000.0	-1000.0	-0.001	-1000.0
TCGA08_rtk_signaling	0.0	11.0	26.0	-0.047	0.05	1000.0	-1000.0	-0.005	-1000.0
LPA receptor mediated events	0.0	82.0	102.0	-0.205	0.068	1000.0	-1000.0	-0.064	-1000.0
Stabilization and expansion of the E-cadherin adherens junction	0.0	62.0	74.0	-0.129	0.067	1000.0	-1000.0	-0.063	-1000.0
E-cadherin signaling in the nascent adherens junction	0.0	45.0	76.0	-0.021	0.058	1000.0	-1000.0	-0.054	-1000.0
Sumoylation by RanBP2 regulates transcriptional repression	0.0	0.0	27.0	-0.0	0.078	1000.0	-1000.0	-0.031	-1000.0
IL2 signaling events mediated by STAT5	0.0	9.0	22.0	-0.045	0.043	1000.0	-1000.0	-0.034	-1000.0
Class I PI3K signaling events	0.0	33.0	73.0	-0.041	0.04	1000.0	-1000.0	-0.036	-1000.0
Arf6 trafficking events	0.0	15.0	71.0	-0.046	0.045	1000.0	-1000.0	-0.026	-1000.0
Regulation of Telomerase	0.0	49.0	102.0	-0.101	0.086	1000.0	-1000.0	-0.045	-1000.0
IGF1 pathway	0.0	45.0	57.0	-0.049	0.07	1000.0	-1000.0	-0.046	-1000.0
VEGFR1 specific signals	0.0	48.0	56.0	-0.038	0.042	1000.0	-1000.0	-0.055	-1000.0
S1P3 pathway	0.0	30.0	42.0	-0.021	0.052	1000.0	-1000.0	-0.029	-1000.0
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha	0.0	14.0	33.0	-0.134	0.09	1000.0	-1000.0	-0.032	-1000.0
Rapid glucocorticoid signaling	0.0	0.0	20.0	-0.0	0.045	1000.0	-1000.0	-0.0	-1000.0
Neurotrophic factor-mediated Trk receptor signaling	0.0	34.0	120.0	-0.069	0.095	1000.0	-1000.0	-0.05	-1000.0
PDGFR-beta signaling pathway	0.0	34.0	97.0	-0.069	0.09	1000.0	-1000.0	-0.049	-1000.0
Signaling events mediated by PRL	0.0	17.0	34.0	-0.091	0.057	1000.0	-1000.0	-0.035	-1000.0
Class IB PI3K non-lipid kinase events	0.0	0.0	3.0	-0.031	0.031	1000.0	-1000.0	-0.019	-1000.0
S1P4 pathway	0.0	20.0	25.0	-0.02	0.052	1000.0	-1000.0	-0.025	-1000.0
E-cadherin signaling events	0.0	3.0	5.0	0.008	0.034	1000.0	-1000.0	0.019	-1000.0
p38 MAPK signaling pathway	0.0	26.0	44.0	-0.071	0.065	1000.0	-1000.0	-0.024	-1000.0
Arf1 pathway	0.0	6.0	54.0	-0.001	0.048	1000.0	-1000.0	-0.017	-1000.0
Alternative NF-kappaB pathway	0.0	0.0	13.0	0.0	0.1	1000.0	-1000.0	-0.0	-1000.0
Regulation of Androgen receptor activity	0.0	40.0	70.0	-0.102	0.049	1000.0	-1000.0	-0.04	-1000.0
Ras signaling in the CD4+ TCR pathway	0.0	10.0	17.0	-0.007	0.048	1000.0	-1000.0	-0.025	-1000.0
Aurora B signaling	0.0	55.0	67.0	-0.115	0.079	1000.0	-1000.0	-0.047	-1000.0
Total	80	8061	7203	-13.3429767183	8.46541847352	131000	-131000	-4.48446776696	-131000